Xiaowen Cui
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
The noncanonical function of liver-type phosphofructokinase potentiates the efficacy of HDAC inhibitors in cancer.
Journal: Signal transduction and targeted therapy
Published: March 29, 2025
Characteristics and outcomes of primary and secondary resistance to immune checkpoint inhibitors in hepatocellular carcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: March 16, 2025
Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysis.
Journal: Frontiers in oncology
Published: August 19, 2024
Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Journal: Frontiers in immunology
Published: February 15, 2023
URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers.
Journal: Nature communications
Published: December 26, 2022
Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases.
Journal: Genes & diseases
Published: July 26, 2022
The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma.
Journal: Cell death & disease
Published: January 16, 2022
Bacillus dabaoshanensis sp. nov., a Cr(VI)-tolerant bacterium isolated from heavy-metal-contaminated soil.
Journal: Archives of microbiology
Published: August 28, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026